On-Demand Content | Virtual Event

Agenda

Come visit our virtual lobby and connect with fellow attendees. You can chat, video, and even make a list of the people you want to meet and the knowledge you’re looking to gain through our bespoke 1:1 match-making services.
The digital revolution has been accelerated by COVID-19 and the dawn for Medical Affairs to seize momentum is upon us.   However, digital in Medical Affairs has not peaked and may be considered by some to still be in its infancy compared to other Pharma functions like digital marketing.

Understanding how to apply the right mindset to ‘digital’ for Medical Affairs is key to ensuring Medical Affairs organizations are primed to accelerate their transformation fueled by digital and data. And importantly, how do you prioritize a digital strategy for Medical Affairs becomes incredibly important especially given how broad digital can be.

  • Kicking off the conference by learning how to have the right digital mindset to drive Digital Medical Affairs in your organization
  • Understand how to seek out value from your digital initiatives in Medical Affairs
  • Gain insights into how to build the digital medical affairs function
Robert Stevens
Vice President, Global Head Digital Medical Affairs
NOVARTIS
Necessity is the mother of invention” (Plato). COVID-19 has been a driver of the need for medical affairs to employ new and digital approaches to stakeholder engagement and insight gathering. For the many small- to mid-sized companies that were not already on a path to digital adoption, the pandemic has changed the question of organizational buy-in for new digital tools and strategies from ‘should we?’ to ‘how can we?’ This session is a case study in how to approach moving from an analog to digitally-capable medical organization.

Key elements:
  • Discuss steps to go from zero to digital
  • Identify a framework to consider the landscape of medical affairs digital engagement opportunities
  • Discuss strategic medical plan development for digital engagement
Barry Lubarsky
Executive Director, Medical Affairs Strategy, 
ALKERMES
Implementing an omnichannel strategy is not a new concept, yet medical affairs teams are still in the early stages of adoption. As we shift back to in person events, now is the time to introduce an omnichannel approach to deliver a one-of-a-kind, seamless user experience across multiple touch points

In this panel discussion we will discuss:
  • Defining omnichannel strategies in medical affairs
  • How organizations are measuring success of these campaigns
  • Best practices for getting started
Moderator:
Andrea Bielecki
CEO
INVIVO

Panelists:
Pardis Tabrizi, PharmD
Director, Global Medical Affairs
PFIZER

Stacey Gorski, Ph.D.
Director, North America
Medical Excellence and Strategic Projects
SANOFI

Romano Del Fiacco
Global Medical Education Advisor
ELI LILLY
A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speakers but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts and conference speakers.
  • How to improve the engagement experience from medical communications
  • Attaching an ROI to engagement: how to measure the engagement experience vs. engagement scores
  • Measuring medical impact through analytics
  • Getting internal buy in and aligning on priorities for overlapping digital initiatives with medical and commercial
  • Creating demand for and getting buy in to digital modalities across the business
Rajesh Ghosh
Head, Digital Safety and Decision Support
GENENTECH
  • Why measuring impact matters?
  •  The digital transformation of medical affairs KPIs
  •  Omni-channel engagements and metrics
  •  A new model to measure the value of medical teams
  •  Predictions on value proposition of medical affairs
Luca Dezzani
Medical Franchise Head
ASTRAZENECA
  • Understand how the medical affairs function is evolving to meet the needs of healthcare providers and their patients
  • Review actionable, innovative, and data-driven tactics to enhance the value proposition of medical affairs
  • Learn how to leverage AI and data for a more effective and efficient approach to field medical operations
Andrew Rosen
Director of Global Data Generation
AKCEA THERAPEUTICS
  • Understanding the arrival of ‘disruptive’ trends such as real-world data, sensors, artificial intelligence, precision medicine and physician communities to further accelerate the strategic importance of eMedical programmes across the product life cycle
  • Starting multichannel medical education during phase II/III to establish unmet needs, thought leader advocacy, a strong medical platform and the core scientific positioning of the product to maximise uptake at launch
  • Maximize data and messages dissemination for uptomial product awareness via the full range of multichannel vehicles to address internal and external audiences
  • Understanding the element of multichannel, what does it mean to be effective in a phone, email, skype
Wagdy Youssef, MD., MBA
Senior Director US Medical Communication, Medical Information, Publication and Digital Transformation
BAYER
A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speakers but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speakers may have questions for you as well!
Come visit our virtual lobby and connect with fellow attendees. You can chat, video and even make a list of the people you want to meet and knowledge you’re looking to gain through our bespoke 1:1 match-making services.
  • Establishing a digital engagement task force that includes both home office and field medical teams as well as cross-functional team members with a defined structure, capability and mandate to make rapid decisions
  • Using downtime that field teams may currently be experiencing to upskill your people with necessary digital capabilities and proactively establish customer feedback mechanisms to facilitate test/learn/iterate rollout approaches moving forward
  • When and when not to use Digital in Medical Affairs
  • Engaging with Digital Influencers to reach groups of HCPs that are otherwise difficult to engage and to reach them through colleagues they trust and have elected to follow
John Wahba
Global Medical Affairs Director, Digital & Comms
VIIV HEALTHCARE
  • Using virtual advisory board to increase interaction with key opinion leaders (KOLs)
  • Implement a new way of communication allowing KOLs to provide advice to pharmaceutical companies without disrupting clinical workflow
  • Utilizing Telemedicine or Virtual consultation to enhance patient experience and engagement
  • Understand new ways MSLs can collect insights without interacting with HCPs directly
Moderator:
Bryan A. Wilson
Regional Medical Scientific Director - Cardiovascular and Metabolism
MERCK

Panelists:
Sean Markwardt, PhD
Vice President, Medical Affairs
AVANT HEALTHCARE

Bernard Ng
VP Head of Global Medical and  Clinical Affairs for Bayer Consumer Healthcare,
BAYER

Kunj Gohil
Director, Digital Strategy Lead [New Engagement Models] - Global Medical Affairs 
NOVARTIS

Rishi Ohri
Sr. Director, Digital Excellence, Medical Affairs
ASTELLAS
  • Collecting, organizing, and translating insights into actionable inputs that can inform the medical strategy
  • Applying AI to help to process insights from different sources and make them available to medical affairs professionals in a format that simplifies the interpretation and make it easier to find patterns that are informative for the company
  • Predicting what contents are of highest interest to each Heath Care Professional (HCP) and implementing a feedback loop that will make the content more useful and personalized in real time.
Stanislav Glezer
WorldWide VP, Medical Affairs and Business Development, Diabetes Care
BD
A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speakers but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speakers may have questions for you as well!
  • Best practices for investigator engagement and research operations management
  • Real-world data collection strategies to generate compelling evidence which can transform clinical outcomes and enhance access for patients to products
  • Positioning your science especially your ability to combine, analyze, and interpret disparate datasets to inform your interactions with stakeholders and ultimately improve patient outcomes with electronic health outcome measures
Peter Covitz
Senior Director, Medical Affairs and Head, Medical Research Operations
BIOGEN
Many medical affairs teams underestimate the value of the data that they create and consume. The utility of analytics is often misunderstood and developing a data strategy can be overwhelming. As biotech embraces more digital solutions, an investment into data-driven decision making and a self-service analytics model becomes crucial in showcasing ROI and value.

  • Understand the gaps, opportunities, data silos, and current data landscape of your team
  • Start small and utilize a structured framework to bring data to the hands of your users to increase adoption and create a data-oriented department
  • Avoid investing in “shiny” AI/ML vendors or projects without having a defined ROI and business use case
  • Case Study 1: Natural Language Processing in Medical Information & Field Medical
  • Case Study 2: Descriptive/Predictive Capabilities of Medical-Legal-Regulatory data in Medical Affairs Operations
Imtiyaz Hossain
Global Associate Director, Data Science Lead, Medical Affairs
TAKEDA
  • Building a strong foundations for an innovative & a high standard Medical Affairs organization through the 4 Ps: Product, People, Process and Performance
  • Providing a superior customer value while working backwards to solve our customers problems
  • Shaping the digital environment while building a ground up culture of innovation, collaboration and execution excellence
Dotan Ran
Director, Innovation and Capabilities, Medical & Scientific Affairs
MERCK
Digital Transformation is less about transformation of technology and more about the transformation of people to accept digital technology . Technology is often just the enabler. COVID-19 just accelerated the digital transformation process that was already underway. It is important to understand the principles behind selecting the right technology, the hybrid mindset of future digitally transformed teams and the importance of training the teams to accept the technology to address the fundamental business needs.

The session will cover:
  • The Three T’s of Digital Transformation: Technology, Teams and Training
  • The importance of remaining extremely flexible when it comes to technology assessment.
  • The Importance of remaining rigid in our expectations in what business problems these technologies need to solve for.
  • Applying people management concepts to motivate people to transform digitally.
  • The need to put HEALTHCARE filters on these technologies so that they measure up to the robustness of science, that forms the bedrock value of medical affairs teams.
Raweesh Chaudhary, B. Pharm, MBA, CCPE
Director, Medical Affairs (Cardiovascular and Metabolic Diseases)
ASTRAZENECA
Digital solutions are no longer a “nice to have”. They are an integral component of any effective integrated Medical Affairs strategy. COVID-19 has accelerated a digital transformation that was already underway – and with it has brought a whole host of opportunities for even the smallest companies to maintain and grow their reputation in this busy and ever-changing landscape.

The session will cover:
  • How the pandemic has accelerated the digital transformation of Medical Affairs and presented new opportunities to smaller companies
  • Practical examples of cost effective and innovative digital solutions that have helped a small biotech make a big impact
  • The importance of staying agile in a digital world and what to expect in the next phase of our “new normal”
Reza Safaei, MD
Vice President, Head of Medical Affairs International
APELLIS PHARMACEUTICALS
A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speakers but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speakers may have questions for you as well!